Welcome!
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Морозов Дмитрий
Dmitry Morozov
General Director, BIOCAD
Quotes
07.06.2019
SPIEF 2019
Identifying Effective Strategies for the Chinese Consumer Market
The Chinese population is growing old. <…> Despite the success of Chinese producers, the main share of hi-tech expensive medicaments still comes from abroad. China buys American and European medications that are hi-tech, expensive, cutting edge. <…> Now we are successfully winning our own market back from international pharmaceutical companies
07.06.2019
SPIEF 2019
Identifying Effective Strategies for the Chinese Consumer Market
If we do not synchronize regulation, it is going to be a huge barrier for the development of economic relations between our countries. <…> [For example], registration of medications. I think the most significant contribution would be if Chinese medications were imported here, and our medicactions were exported to China
07.06.2019
SPIEF 2019
Creating innovative medicines and new horizons in healthcare
We are a big country; our logistics is complicated. We are talking about 5,000 patients. How do we build a centralized cell treatment centre for the patients? We need to understand that the fastest way is to help businesses that already have patients. Our government centres must help businesses to create such technologies. That is the only path towards practical implementation
06.06.2019
SPIEF 2019
A Substantive Dialogue Between Global Pharmaceutical Players and BRICS Economies on the Rules of Fair and Equitable Competition
In terms of the regulatory framework, we need there to be clear and understandable rules. However, it is often the case that rules are based on spur-of-the-moment populist decisions
13.02.2019
Healthy Life Forum: Towards 80+ 2019
A System of Universal Medicine Provision: Key to Achieving the National Goal
e’re seeing absolutely unacceptable things in regards to patent law. I believe that right now what we’re seeing with violations of patent laws, no matter if they’re domestic or foreign producers, is unacceptable. In pharmaceutics, intellectual property rights are basic rights that must be protected on all levels
13.02.2019
Healthy Life Forum: Towards 80+ 2019
Reducing Mortality from Non-Communicable Diseases: Implementing Federal Projects
Health is our common task. Not only for states, but also for all citizens,
11.09.2018
EEF 2018
Crossroads on the Silk Road
Russian high-tech companies have great prospects in China. On the one hand, our Chinese colleagues are developing quite rapidly, <...>, but on the other hand we understand that in such areas as biotechnology, we have great potential, because we are witnessing a situation when China's healthcare requires medications that already exist in Russia
25.05.2018
SPIEF 2018
Forcast-2100: Technologies of the Future?
We use all kinds of technologies to study nature, but we haven’t really got to know it. We try to use our technological knowledge of the nature of things to understand things that are impossible to understand. … Using technological approach, we will still lag many steps behind the way we should live.
25.05.2018
SPIEF 2018
Forcast-2100: Technologies of the Future?
The world is unfair from the get-go, it’s been created that way. I don’t believe in universal fairness, such is the human nature. … Hi-tech treatment will thus far remain a thing for the rich, and so will increased longevity
24.05.2018
SPIEF 2018
Breakthrough Technologies in Medicine: Evolution, Revolution, Organization
Last year we became No. 1 in our segment of oncology. The international pharmaceutical companies have always kept this place — now they are not there. <...> Our market is growing at a tremendous pace, and we have very high potential
24.05.2018
SPIEF 2018
Breakthrough Technologies in Medicine: Evolution, Revolution, Organization
The only question is when all of this will appear on the market,